Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (134)
2024
-
A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)
Cerebrovascular Diseases
-
ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy
Blood, Vol. 143, Núm. 18, pp. 1807-1815
-
Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis
Journal of Medical Economics, Vol. 27, Núm. 1, pp. 1379-1387
-
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-related cancer
-
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466
-
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385
-
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
Pituitary, Vol. 27, Núm. 5, pp. 497-506
-
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.
Digestive and Liver Disease
-
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1647-1663
-
Natural history and surgical outcomes of Rathke’s cleft cysts: a Spanish multicenter study
Frontiers in Endocrinology, Vol. 15
-
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-Related Cancer, Vol. 31, Núm. 7
-
Profile of Patients With Moderate-to-Severe Atopic Dermatitis and Chronic Urticaria Undergoing Biological Treatment in Hospital Allergy Units in Spain: First Report of the Alergodata Registry
Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 2, pp. 131-133
-
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
Leukemia
-
Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)
Trials, Vol. 25, Núm. 1
2023
-
ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482
-
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer (Scientific Reports, (2015), 5, 1, (17499), 10.1038/srep17499)
Scientific Reports
-
COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
BMC Health Services Research, Vol. 23, Núm. 1
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo
JACC: Cardiovascular Imaging, Vol. 16, Núm. 12, pp. 1567-1580